Evidence map›Paper›PMID 39535788›Full record

ArticleInvestigative ophthalmology & visual science2024

Genetic and Cellular Basis of Impaired Phagocytosis and Photoreceptor Degeneration in CLN3 Disease.

Jimin Han, Sueanne Chear, Jana Talbot, Vicki Swier, Clarissa Booth, Cheyenne Reuben-Thomas, Sonal Dalvi, Jill M Weimer, Alex W Hewitt, Anthony L Cook and 1 more

Abstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Jimin HanDepartment of Ophthalmology, University of Rochester, Rochester, New York, United States.
Sueanne ChearWicking Dementia Research and Education Centre, University of Tasmania, Tasmania, Australia.
Jana TalbotWicking Dementia Research and Education Centre, University of Tasmania, Tasmania, Australia.
Vicki SwierPediatrics & Rare Diseases Group; Sanford Research, Sioux Falls, South Dakota, United States.
Clarissa BoothPediatrics & Rare Diseases Group; Sanford Research, Sioux Falls, South Dakota, United States.
Cheyenne Reuben-ThomasDepartment of Ophthalmology, University of Rochester, Rochester, New York, United States.
Sonal DalviDepartment of Ophthalmology, University of Rochester, Rochester, New York, United States.
Jill M WeimerPediatrics & Rare Diseases Group; Sanford Research, Sioux Falls, South Dakota, United States.
Alex W HewittMenzies Institute for Medical Research, University of Tasmania, Tasmania, Australia.
Anthony L CookWicking Dementia Research and Education Centre, University of Tasmania, Tasmania, Australia.
Ruchira SinghDepartment of Ophthalmology, University of Rochester, Rochester, New York, United States.

Funding

Delineating the role of TIMP3 in macular degenerationR01EY028167 · NEI · UNIVERSITY OF ROCHESTER · PI SINGH, RUCHIRA · 2017 to 2025
$3.8M
Determining the role of CLN3 in the eyeR01EY030183 · NEI · UNIVERSITY OF ROCHESTER · PI SINGH, RUCHIRA · 2019 to 2022
$2.0M
Using hiPSCs to develop physiologically-relevant outer retina tissue mimeticsR01EY033192 · NEI · UNIVERSITY OF ROCHESTER · PI BENOIT, DANIELLE S., SINGH, RUCHIRA · 2022 to 2024
$1.7M
NEI NIH HHS R01 EY028167NEI NIH HHS R01 EY030183NEI NIH HHS R01 EY033192
6 · The paper itself

Abstract

Purpose: CLN3 Batten disease (also known as juvenile neuronal ceroid lipofuscinosis) is a lysosomal storage disorder that typically initiates with retinal degeneration but is followed by seizure onset, motor decline and premature death. Patient-derived CLN3 disease induced pluripotent stem cell-RPE cells show defective phagocytosis of photoreceptor outer segment (POS). Because modifier genes are implicated in CLN3 disease, our goal here was to investigate a direct link between CLN3 mutation and POS phagocytosis defect. Methods: Isogenic control and CLN3 mutant stem cell lines were generated by CRISPR-Cas9-mediated biallelic deletion of exons 7 and 8. A transgenic CLN3Δ7-8/Δ7-8 (CLN3) Yucatan miniswine was also used to study the impact of CLN3Δ7-8/Δ7-8 mutation on POS phagocytosis. POS phagocytosis by cultured RPE cells was analyzed by Western blotting and immunohistochemistry. Electroretinogram, optical coherence tomography and histological analysis of CLN3Δ7-8/Δ7-8 and wild-type miniswine eyes were carried out at 6, 36, or 48 months of age. Results: CLN3Δ7-8/Δ7-8 RPE (CLN3 RPE) displayed decreased POS binding and consequently decreased uptake of POS compared with isogenic control RPE cells. Furthermore, wild-type miniswine RPE cells phagocytosed CLN3Δ7-8/Δ7-8 POS less efficiently than wild-type POS. Consistent with decreased POS phagocytosis, lipofuscin/autofluorescence was decreased in CLN3 miniswine RPE at 36 months of age and was followed by almost complete loss of photoreceptors at 48 months of age. Conclusions: CLN3Δ7-8/Δ7-8 mutation (which affects ≤85% of patients) affects both RPE and POS and leads to photoreceptor cell loss in CLN3 disease. Furthermore, both primary RPE dysfunction and mutant POS independently contribute to impaired POS phagocytosis in CLN3 disease.

Indexed as

ElectroretinographyMembrane GlycoproteinsMolecular ChaperonesNeuronal Ceroid-LipofuscinosesPhagocytosisTomography, Optical CoherenceAnimalsBlotting, WesternCells, CulturedHumansImmunohistochemistryInduced Pluripotent Stem CellsMutationRetinal DegenerationRetinal Photoreceptor Cell Outer SegmentRetinal Pigment EpitheliumCLN3 protein, humanMembrane GlycoproteinsMolecular Chaperones

Identifiers

PMID39535788
PMCPMC11563035

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.